Amgen prevails on appeal in the US patent dispute involving generic psoriasis medications.

Published Date: 22 Apr 2023

On Wednesday, Amgen persuaded a US appeals court to uphold patents that prevented generic versions of its popular psoriasis drug Otezla from being developed by Zydus Pharmaceuticals and Sandoz, a division of Novartis.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Vaccine shows promise for pancreatic cancer, study finds

2.

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.

3.

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

4.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

5.

Tumor characteristics found to differ for melanomas in children, teens and young adults


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot